(1)
Comment on "Apixaban Vs. Aspirin for Stroke Prevention in People With Subclinical Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack: Subgroup Analysis of the ARTESiA Randomized Controlled Trial". Bleeding Thromb Vascul Biol 2025, 4 (2). https://doi.org/10.4081/btvb.2025.179.